AEON Biopharma is a biopharmaceutical company developing ABP-450, a botulinum toxin complex, as a biosimilar to Botox (onabotulinumtoxinA) for therapeutic indications. The company holds exclusive development and commercialization rights for ABP-450 in the U.S., Canada, EU, UK, and certain other territories. ABP-450 is manufactured by Daewoong Pharmaceutical and is the same toxin marketed as Jeuveau for cosmetic use. AEON is pursuing FDA approval via a Section 351(k) BLA targeting therapeutic indications, with an estimated market size of at least $3.3 billion in 2025.
Q2 FY2026 — expected 2026-09-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-30 | 2025-12-31 | 0001837607-26-000019 | EDGAR | 96K words |
| 2025-03-24 | 2024-12-31 | 0001837607-25-000022 | EDGAR | 108K words |
| 2024-03-29 | 2023-12-31 | 0001837607-24-000015 | EDGAR | 112K words |
| 2023-02-22 | 2022-12-31 | 0001104659-23-023947 | EDGAR | — |
| 2022-03-28 | 2021-12-31 | 0001104659-22-038759 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001104659-21-044781 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001837607-26-000062 | EDGAR | 35K words |
| 2025-11-14 | 2025-09-30 | 0001837607-25-000085 | EDGAR | 31K words |
| 2025-08-12 | 2025-06-30 | 0001837607-25-000066 | EDGAR | 30K words |
| 2025-05-14 | 2025-03-31 | 0001837607-25-000050 | EDGAR | 28K words |
| 2024-11-13 | 2024-09-30 | 0001837607-24-000093 | EDGAR | 34K words |
| 2024-08-12 | 2024-06-30 | 0001558370-24-011896 | EDGAR | 70K words |
| 2024-05-14 | 2024-03-31 | 0001837607-24-000063 | EDGAR | 31K words |
| 2023-11-13 | 2023-09-30 | 0001558370-23-018706 | EDGAR | 48K words |
| 2023-07-21 | 2023-06-30 | 0001104659-23-082959 | EDGAR | — |
| 2023-05-17 | 2023-03-31 | 0001104659-23-061821 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001104659-22-117341 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001104659-22-090142 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-12 | 0001837607-26-000061 | EDGAR | 2K words |
| 2026-08-03 | 0001837607-26-000057 | EDGAR | 1K words |
| 2026-07-23 | 0001837607-26-000055 | EDGAR | 1K words |
| 2026-07-15 | 0001837607-26-000052 | EDGAR | 1K words |
| 2026-04-03 | 0001837607-26-000025 | EDGAR | 1K words |
| 2026-03-30 | 0001837607-26-000018 | EDGAR | 2K words |
| 2026-03-09 | 0001837607-26-000009 | EDGAR | 7K words |
| 2026-01-21 | 0001837607-26-000005 | EDGAR | 1K words |
| 2026-01-12 | 0001837607-26-000002 | EDGAR | 5K words |
| 2025-12-15 | 0001837607-25-000092 | EDGAR | 1K words |
135 total filings indexed. 107 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001837607 |
| Ticker | AEON |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.aeonbiopharma.com |
| Listed | 2023-07-24 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AEON (~200 tokens, structured JSON with cryptographic provenance)